Paragon Wealth Strategies, LLC Pfizer Inc Transaction History

Paragon Wealth Strategies, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 27, 2023	BUY	$41.75 - $54.5 $41 - $54	1 Added 1.89%	54 $2,000
Q3 2022 Nov 03, 2022	BUY	$43.76 - $53.42 $2,319 - $2,831	53 New	53 $2,000
Q3 2021 Oct 29, 2021	SELL	$39.25 - $50.42 $4,749 - $6,100	-121 Closed	0 $0
Q2 2021 Jul 12, 2021	BUY	$35.91 - $40.68 $4,345 - $4,922	121 New	121 $5,000
Q4 2019 Jan 27, 2020	SELL	$32.92 - $37.36 $410,742 - $466,140	-12,477 Closed	0 $0
Q3 2019 Oct 30, 2019	BUY	$32.49 - $42.13 $109,328 - $141,767	3,365 Added 36.93%	12,477 $448,000
Q2 2019 Jul 17, 2019	BUY	$36.98 - $41.52 $159,531 - $179,117	4,314 Added 89.91%	9,112 $395,000
Q1 2019 Apr 17, 2019	BUY	$37.5 - $41.2 $179,925 - $197,677	4,798 New	4,798 $204,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Paragon Wealth Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Paragon Wealth Strategies, LLC with notifications on news.